Market Tracker

05/25 4:45pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.8306
Delayed Data
As of May 25
 -0.0493 / -5.60%
Today’s Change
0.75
Today|||52-Week Range
2.50
-37.55%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.88
Today’s open0.81
Day’s range0.77 - 0.85
Volume1,565,605
Average volume (3 months)570,820
Market cap$136.9M
Dividend yield--
Data as of 4:02pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp-0.07-1.29%
NEOSNeos Therapeutics In...+1.99+23.03%
EIGREiger BioPharmaceuti...-0.16-0.79%
RDHLRedhill Biopharma Lt...0.000.00%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer
Jed Andrew Latkin
Chief Scientific Officer &
Senior Vice President
Frederick O. Cope
Corporate headquarters
Dublin, Ohio

Forecasts